U.S. Metals and Mining Stock News

NYSE:KEY
NYSE:KEYBanks

KeyCorp Community Investment Highlights Valuation Gap And ESG Considerations

KeyBank Foundation is providing a $240,000 investment to YWCA North Central Indiana's Strengthening Communities Initiative. The funding supports services for survivors of abuse and underprivileged individuals across the region. This partnership focuses on economic empowerment and social support outcomes rather than traditional financial metrics. For investors tracking KeyCorp (NYSE:KEY), this announcement adds a fresh data point to the non financial side of the story. The company last...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Why Ichor Holdings (ICHR) Is Up 9.6% After Margin-Focused Restructuring And AI Infrastructure Progress

Ichor Holdings recently reported Q4 non-GAAP EPS of US$0.01, modestly ahead of expectations despite restructuring charges tied to exiting its Scotland and Korea operations, and guided Q1 revenue to a US$240 million–US$260 million range. What stands out is that this operational reshaping, alongside Ichor’s role in AI-focused semiconductor hardware infrastructure, is feeding into a stronger margin-recovery story that is gaining attention from analysts. With analysts citing improving gross...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Huntington Bancshares Buybacks And Synergies Reframe Acquisition Integration Story

Huntington Bancshares (NasdaqGS:HBAN) reports progress on its Veritex integration, highlighting execution on recent acquisition activity. The bank cites strong retention of Cadence customers as it continues to combine acquired operations with its core franchise. Huntington accelerates its share repurchase program, with updated 2026 guidance and planned additional buybacks in 2027. The company is targeting about 5% of its shares to be retired by the end of next year and over US$500 million in...
NYSE:FINV
NYSE:FINVConsumer Finance

FinVolution Group NYSE FINV Net Margin At 20% Challenges Cautious Profitability Narratives

FinVolution Group (NYSE:FINV) has put solid headline numbers on the table for FY 2025 so far, with third quarter revenue of about C¥3.5b and basic EPS of C¥2.49, set against trailing 12 month totals of roughly C¥14.0b in revenue and C¥11.05 in EPS. Over recent periods, revenue has moved from around C¥3.2b in the second quarter of 2024 to about C¥3.5b in the third quarter of 2025. Quarterly EPS has ranged between roughly C¥2.12 and C¥2.95, giving investors a clear read on how the top and...
NYSE:CUBI
NYSE:CUBIBanks

Will Stephens’ Rating Upgrade Change Customers Bancorp's (CUBI) Digital Banking and Specialty Lending Narrative?

Earlier this week, research firm Stephens upgraded Customers Bancorp’s rating on its shares from “Underweight” to “Equal Weight,” signaling a shift in its stance on the regional bank’s prospects. The upgrade highlights how external analyst opinions can quickly influence investor sentiment around Customers Bancorp’s evolving business model and risk profile. Next, we’ll examine how Stephens’ more constructive stance could influence Customers Bancorp’s existing investment narrative built around...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Assessing Celcuity (CELC) Valuation After VIKTORIA-1 Data And New Analyst Buy Rating

Celcuity (CELC) is back in focus after publishing Phase 3 VIKTORIA-1 data on its breast cancer drug candidate in the Journal of Clinical Oncology, alongside fresh analyst coverage that has drawn renewed attention from investors. See our latest analysis for Celcuity. The VIKTORIA-1 publication and recent analyst attention come after a sharp rerating, with Celcuity’s 1 year total shareholder return above 10x. Its 30 day and 90 day share price returns of 9.19% and 15.20% suggest momentum has...
NYSE:TDOC
NYSE:TDOCHealthcare Services

A Look At Teladoc Health’s Valuation After Mixed Revenue Beat And Guidance Update

Why Teladoc’s latest earnings are drawing attention Teladoc Health (TDOC) just reported quarterly revenue slightly above expectations, paired with weaker near term guidance but a larger full year outlook increase than sector peers, putting both growth and caution on investors’ radar. See our latest analysis for Teladoc Health. The mixed earnings update appears to have given Teladoc’s share price a short term lift, with a 1 month share price return of 20.65% contrasting with a 1 year total...
NYSE:DOW
NYSE:DOWChemicals

Is Rising Analyst Optimism Reframing Dow’s (DOW) Supply Chain Role in North American Chemicals?

Dow Inc. recently took part in a fireside chat at the 2026 J.P. Morgan Industrials Conference in Washington, D.C., offering investors a webcast, replay, and transcript of management’s latest commentary. This appearance comes as multiple research firms have upgraded their views on Dow, highlighting potential benefits from geopolitical supply chain shifts for North American chemical producers. With that backdrop, we’ll now examine how rising analyst confidence tied to expected supply chain...
NYSE:TGLS
NYSE:TGLSBuilding

Tecnoglass (TGLS) Valuation Check After Recent Share Price Pullback And Mixed Market Signals

Recent share performance and business snapshot Tecnoglass (TGLS) has drawn fresh attention after a mixed stretch in its share performance, with gains over the past week but negative returns over the past month and past 3 months. For context, Tecnoglass operates an architectural glass and windows business with revenue of US$983.61m and net income of US$159.57m, primarily serving commercial and residential construction markets across the United States, Colombia, Panama, and other regions. See...
NYSE:FLO
NYSE:FLOFood

Will a Large Non‑Cash Impairment and Dave’s Killer Bread Momentum Change Flowers Foods’ (FLO) Narrative

In the past quarter, Flowers Foods, Inc. recorded a large non-cash impairment charge on intangible assets, prompting investors to reassess its near-term outlook and risk profile. Despite this accounting setback, the company’s Dave’s Killer Bread brand continues to gain share in the organic bread category, highlighting the strength of its premium, health-focused portfolio. We’ll now examine how the sizable non-cash impairment, alongside resilience in Dave’s Killer Bread, affects Flowers...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

A Look At Blackbaud (BLKB) Valuation As Development Agent AI Tool Reaches General Availability

Blackbaud (BLKB) just rolled out its Development Agent to Raiser’s Edge NXT customers in the U.S., introducing an AI-powered teammate that can autonomously manage donor outreach under human oversight. See our latest analysis for Blackbaud. Despite rolling out the Development Agent and broadening its AI toolkit, Blackbaud’s 30 day share price return of 10.47% and year to date share price return of 26.18% decline sit alongside a 1 year total shareholder return of 31.23% decline. This points to...
NasdaqCM:NN
NasdaqCM:NNSoftware

A Look At NextNav (NN) Valuation After Recent Share Price Momentum

What recent performance tells you about NextNav stock NextNav (NN) has attracted fresh attention after recent price moves. The stock closed at US$16.87 and has shown positive returns over the past week, month, and past 3 months, as well as over the past year. See our latest analysis for NextNav. The share price momentum over the past week and month sits on top of a much stronger total shareholder return over one and three years. This suggests that sentiment around NextNav’s growth potential...
NYSE:BCC
NYSE:BCCTrade Distributors

A Look At Boise Cascade (BCC) Valuation After Earnings Beat And Capacity Expansion Plans

What the latest quarterly beat means for Boise Cascade (BCC) Boise Cascade (BCC) recently reported quarterly earnings per share and revenue ahead of analyst estimates, even as seasonal softness and broader market headwinds weighed on the building materials space. The company is also highlighting anticipated growth in its building materials distribution business, recent facility expansions such as the Thorsby i-line project, and steadier engineered wood products pricing as key elements of its...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Will Qualcomm’s (QCOM) Bigger Dividend and US$20 Billion Buyback Change Its Capital Allocation Narrative?

Earlier this week, Qualcomm’s board approved an increase in its quarterly cash dividend from US$0.89 to US$0.92 per share, lifting the annual payout to US$3.68, and authorized a new US$20.00 billion share repurchase program with no expiration date. Together, the richer dividend and very large buyback underscore management’s emphasis on returning cash to shareholders while the company pursues diversification beyond its core smartphone chip business. We’ll now examine how Qualcomm’s very large...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack’s Alberta Entry Tests Growth Story And Rich Valuation

Shake Shack (NYSE:SHAK) is entering Western Canada with its first Alberta location, expanding its Canadian footprint beyond existing markets. The new restaurant will prioritize Alberta sourced ingredients and community partnerships, including a collaboration with a local artist. The move is positioned as a long term commitment to regional integration, job creation and local engagement. For investors watching NYSE:SHAK, this Alberta opening adds a fresh angle to recent discussions that have...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Brookfield Infrastructure Pivots To AI Data Assets As Valuation Gap Persists

Brookfield Infrastructure Partners (NYSE:BIP) is reshaping its portfolio by rotating out of mature assets and increasing investment in AI factory related data centers and U.S. fiber networks. Management expects the data segment to become one of the partnership's largest business lines, with a rising contribution from digital infrastructure to future revenues. This shift reflects a move toward higher growth infrastructure tied to AI workloads and cloud connectivity. Brookfield Infrastructure...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Is Newell Brands (NWL) Share Slide Creating A Potential Opportunity For Investors?

If you are wondering whether Newell Brands at around US$3.85 is a bargain or a value trap, the key is understanding what that price actually reflects about the business. The share price has moved sharply in recent periods, with a 9.0% decline over the last 7 days, an 18.1% decline over the past month, a 3.5% gain year to date, and a 37.2% decline over the last year, which will influence how investors think about both risk and potential reward. These swings sit against a backdrop of ongoing...
NYSE:OII
NYSE:OIIEnergy Services

How Insider Selling and Institutional Buying Will Impact Oceaneering International (OII) Investors

On March 11, 2026, Oceaneering International Director M. Mcevoy sold 25,678 shares, while institutional investor Algert Global LLC lifted its stake to 649,747 shares. This mix of insider selling and increased institutional ownership highlights a contrast between board-level share reductions and growing professional investor interest in the company. We’ll now examine how Algert Global’s increased stake might influence Oceaneering International’s existing investment narrative and risk-return...
NYSE:IPI
NYSE:IPIChemicals

A Look At Intrepid Potash (IPI) Valuation After Q4 Turnaround And Lithium Project Update

Intrepid Potash (IPI) has drawn fresh investor attention after reporting fourth quarter 2025 results that reduced its net loss to US$0.429 million and confirming plans to enter lithium production through the White Silver Lithium Project. See our latest analysis for Intrepid Potash. The share price has been building momentum, with a 30 day share price return of 26.71% and a 90 day share price return of 56.14%, while the 1 year total shareholder return sits at 45.02%. This reflects growing...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

How Malaysia Expansion and SBTi Target Validation At MKS (MKSI) Has Changed Its Investment Story

Earlier this month, MKS Inc.’s CEO highlighted at Morgan Stanley’s TMT Conference that the company now serves an estimated 85% of global semiconductor fabrication equipment and 70% of electronics and packaging processes, while also advancing new capacity with a 500,000 square-foot Malaysia facility scheduled to open in mid-2026. Separately, MKS’s short-term greenhouse gas reduction targets received Science Based Targets initiative validation and a board member disclosed a US$72,705 insider...
NYSE:WM
NYSE:WMCommercial Services

Waste Management Highlights CFO Transition And Stericycle Integration For Investors

Waste Management (NYSE:WM) has formally recognized outgoing CFO Devina Rankin for her leadership in integrating the Healthcare Solutions business following the Stericycle acquisition. The acknowledgment also highlights her role in supporting the management transition as the company moves to a new CFO. This recognition underscores the importance of the Stericycle deal and the new Healthcare Solutions segment in Waste Management's business mix. For investors watching NYSE:WM, this leadership...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

How Axcelis Technologies' (ACLS) Interim CFO Shift May Reframe Its Capital Allocation Narrative

On March 12, 2026, Axcelis Technologies announced that Senior Vice President of Investor Relations and Corporate Strategy David Ryzhik was appointed Interim Chief Financial Officer, replacing departing CFO James Coogan, who will remain until April 24, 2026 to support the handover. The move places a long‑tenured finance and investor relations specialist at the center of Axcelis’s financial leadership, potentially sharpening how the company aligns capital allocation, messaging, and corporate...
NYSE:WAB
NYSE:WABMachinery

How Wabtec’s Strong Q4 Beat And Confident 2026 Outlook At Westinghouse Air Brake Technologies (WAB) Has Changed Its Investment Story

Westinghouse Air Brake Technologies recently reported a stronger-than-expected fourth-quarter 2025 performance and reaffirmed confident 2026 guidance, emphasizing double-digit adjusted EPS growth, record cash generation, and support from a multi-year backlog despite industry headwinds. Around the same time, Executive Vice President of Sales & Marketing Gina Trombley sold 4,013 shares, highlighting ongoing insider selling that contrasts with the company’s upbeat operational outlook. Next,...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

New Aficamten HCM Data On Exercise Capacity And Flexibility Might Change The Case For Investing In Cytokinetics (CYTK)

Cytokinetics recently announced that four presentations on MYQORZO™ (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy were delivered at the American College of Cardiology 2026 Annual Scientific Session, highlighting new analyses from the SEQUOIA-HCM, MAPLE-HCM, and FOREST-HCM trials. The data underscored that aficamten improved exercise capacity versus placebo and metoprolol, maintained efficacy across patients with and without hypertension, and showed reassuring safety...